November 7, 2022
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers Simplifies biomarker assay development and validation Creates end-to-end spatial phenotyping workflow when integrated with the PhenoImager platforms...

Continue Reading
November 7, 2022
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
Q3 2022 revenue $18.9 million, 40% y/y growth Raising FY 2022 revenue guidance range to $73-75 million MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter...

Continue Reading
November 3, 2022
Akoya to Participate at Three Upcoming Investor Conferences
MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be participating in three upcoming investor conferences. Stephens Annual Investment Conference (Nashville, TN) Fireside Chat on...

Continue Reading
October 11, 2022
Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022
MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will release financial results for the third quarter of 2022 after the market close on Monday, November 7 th , 2022....

Continue Reading
August 31, 2022
Akoya to Participate at Four Upcoming Investor Conferences
MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in four upcoming investor conferences. H.C. Wainwright 24 th Annual Global Investment Conference (New York, NY)...

Continue Reading
August 8, 2022
Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q2 2022 revenue $17.9 million, 37% y/y growth Raising FY 2022 revenue guidance range to $71-74 million MARLBOROUGH, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the second quarter...

Continue Reading
July 27, 2022
Akoya to Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be participating in two upcoming investor conferences. UBS Genomics 2.0 and MedTech Innovation Conference Fireside Chat – Brian...

Continue Reading
July 12, 2022
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022
MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2022 after the market close on Monday, August 8 th , 2022....

Continue Reading
June 28, 2022
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
The OncoSignature ® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers The OncoSignature ® test will run on Akoya’s PhenoImager™ Solution...

Continue Reading
June 1, 2022
Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting
PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platform MARLBOROUGH, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company ® , will present for the first time, data generated using its...

Continue Reading
Displaying 1 - 10 of 23

Search Investor Relations